The Pfizer Global Medical Grants and The George Washington University (GWU) are proud to announce the renewal of their successful collaborative grant opportunity focused on broad implementation of the Teledermatology Help Desk Clinic model in underserved areas across the United States (US) as a means to expand access to quality-based care for Inflammatory Dermatoses including Atopic Dermatitis (AD) and other inflammatory dermatologic conditions.
Donor Name: Pfizer
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 11/11/2025
Size of the Grant: $100,000 to $500,000
Grant Duration: 2 Years
Details:
Specific populations are at greatest risk for physical, emotional, and financial losses associated with inflammatory dermatoses. It is well established that there are significant racial disparities in health care and disease burden. The underlying causes of health disparities are complex and include social and structural determinants of health, racism and discrimination, economic and educational disadvantages, health care access and quality, individual behavior, and biology. Delayed access to care can result from a wide array of additional factors, from patients being worried about cost, the office or clinic was not open when needed, patient did not have transportation, patient had to wait too long to see physician, patient could not afford prescriptions, patient was unable to reach physician on telephone, and patient was unable to get an appointment soon all contribute to this burden.
Telemedicine has emerged as a critical component of dermatology care delivery as a result of the COVID-19 pandemic and will hopefully be so for the foreseeable future. However, improved technology access and literacy, healthcare professional training in identifying disease via telemedicine in all skin tones, and quality of care metrics are sorely needed to optimize telemedicine. It is critical and equally important to provide accessible patient education on telemedicine best practices and on long term management strategy of their disease in tandem with quality dermatologic care.
Areas of Interest
The intent of this RFP isto encourage organizations to submit a quality improvement project that aims to achieve quality improvement for Healthcare Practitioners (HCPs) that treat medical dermatology conditions. Programs to help HCPs meet the needs of patients with medical dermatologic conditions through telemedicine best practices and long-term management strategy of their disease in tandem with quality dermatologic care will be considered. Programs would focus on:
- The education of HCPs regarding effective implementation of telehealth in their practice in combination with the development, implementation, and/or optimization of innovative or existing tools designed to facilitate diagnosis, treatment and shared decision making in a remote interaction between underserved patients and HCPs will be considered.
- This program will improve dermatologists’ ability to:
- Partner and collaborate with community stakeholders
- Train students, dermatology residents, and faculty on telemedicine best practices and clinical diagnosis during synchronous virtual visits
- Recruit, engender trust and educate those with the greatest need to access dermatologic care
- Identify strategies to sustain community-based care interventions to provide ongoing free care.
Funding Information
Individual projects requesting up to a maximum of $250,000 will be considered.
Grant Period
March 2026 – September 2027.
Eligibility Criteria
- The following may apply: Organizations with expertise in the care and treatment of patients with inflammatory skin conditions, including medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
- If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- Organizations are encouraged to have collaborators such as community partners who may serve a crucial role.
- Applicants are encouraged to detail project sustainability plans following the grant period.
- Only organizations are eligible to receive grants, not individuals or physician-owned medical practice groups/private clinics.
For more information, visit Pfizer.
